1 per year with family/personal history of MM and/or personal history of 3 DN 2. Lesions should be excised with a 2mm margin if MM cannot be ruled out 3. All patients with DN are taught self-examination Methods: We completed a retrospective study at four plastic surgery units in the South West. All patients 16 years with a histological diagnosis of DN or MM were evaluated. Results: 42 lesions in 40 patients, mean age 11 years were analysed over a 10-year period. 86% underwent excision biopsy; 68% of these were excised with a 2mm margin. 20 patients were followed-up, mean duration 9 months. 5% of all lesions excised were found to be MM. 13% of patients discharged had documented discussion about self-examination. Conclusions: The benefits and costs associated with out-patient surveillance in this patient cohort remain controversial. We recommend suspicious lesions are excised with a 2 mm margin. Self-examination should be advocated and documented for all patients. National standards are required to standardize management. Introduction: This study presents the outcomes of ectropion treatment at the Canniesburn Plastic Surgery Department Glasgow. Method: Patients with ectropion were identified retrospectively from the theatre database between 1998-2008. Case notes were searched for clinical information looking at aetiology, ectropion classification, recurrence rates and complications as primary outcomes.
0869: TEN-YEAR EXPERIENCE OF MANAGING ECTROPIONS AT
Results: Underlying aetiology consisted of fifty-six secondary to skin cancer, four cases post-burns injury, five cases due to facial palsy, five cases from benign causes, five cases from trauma and four of unknown aetiology. Documentation of ectropion classification was poor with fifty patients (63%) having no classification specified. Of the seventy-nine patients, 53% were treated with a single procedure. 37% required 2-4 operations and 10% required 5 or more operations. High re-operation rates were noted in the facial palsy (80%) and skin cancer (11%) cohort. Complications included six infections (8%) and two wound dehiscence (3%). Conclusion: Ectropion was poorly classified and documented in patient notes. Surgical treatment was associated with a recurrence rate of 47%, with high frequency of re-operations noted in facial palsy and skin cancer groups. Accurate classification of ectropion may help in stratifying surgical management according to ectropion type and underlying aetiology. Introduction: At Frenchay Hospital, we have developed a protocol for the discharge of patients following lymph node dissection (LND) for skin cancer within 72 hours post-operatively. This study reviews the outcome of the new discharge algorithm and any financial benefits incurred. Methods: Data was collected on the demographics and outcome of 50 consecutive patients operated by a single surgeon for LND for skin cancer, over a 16 months period. We also reviewed the length of hospital stay and any savings made. Results: 50 patients (31M: 19F) with a mean age of 66.1 years were recruited. 22 axillary, 15 neck and 13 groin dissections were performed. 62% of patients were operated upon within 2 weeks of being seen in clinic. The mean hospital stay was 1.9 days, compared to 9.5 days prior to the new discharge algorithm and single surgeon operator. The complication rate reduced from 50% to 24%. Financially, this resulted in 380 bed days saved over 16 months, equating to a saving of £83,600 (@£220/bed day).
Conclusion:
The presented algorithm is an efficient and safe pathway from consultation to safe discharge, with the reduction in hospital stay and significant financial gains. As surgeons we are under increasing pressure to improve efficiency and cost saving without negatively impacting on the quality and safety of our patient's care. Published rates of red cell transfusion in free flap based breast reconstruction range widely (18-80%). We felt that our transfusion rates were low enough that routinely cross matching blood was likely to be a poor use of resources. We retrospectively reviewed a year of free flap based breast reconstruction activity at a regional centre. There had been 141 free flaps performed on 130 patients. One patient received an elective pre-operative platelet transfusion and five patients received red cell transfusions (5/130, 3.8%). Two patients received blood intra-operatively whilst the rest received red cells over days 1 to 4 post-op. None of the patients had abnormal antibodies and all could have safely received universal donor (O negative) blood. 124 patients had blood needlessly cross matched at significant expense. The patients that did require transfusion could either have received universal donor blood or have safely waited for blood to be cross matched. We would encourage other departments to review their practice as a potential area for improving cost efficiency without any additional increase in risk.
1184: ATYPICAL FIBROXANTHOMA: 10 YEAR SURGICAL EXPERIENCE, DO WE NEED GUIDELINES Amir Sadri, Debbie Hunt, Leila Touil, Ahmed El Gawad, Mohammed Maher, Ali Juma. Countess Of Chester Hospital, Chester, UK. Introduction: Atypical fibroxanthoma (AFX) is a malignant derma tumour. A lack of appreciation for this tumour can lead to loss to follow-up and lack of treatment. No guidelines exist for the management of AFX. We present our 10 year experience with these malignant tumours of the skin. Results: There were 100 patients in the primary study and 76 in the reaudit. The number of patients whose lesion was not identifiable from the referral letter decreased from 30% to 23.7%. The number of patients whose lesion could not be identified by either referral letter or patient themselves fell to 9.2% from 13%. There was an increase in inclusion of photographs from 3.0% to 9.3% Conclusions: Use of photographic referral for suspicious skin lesions is under-utilised in our service. Relying on the patient or the referral text to correctly identify the lesion leaves room for error. The second audit shows small improvements but further education is needed to meet our target of pictorial localisation with each referral.
1279: RE-EXCISION OF BCCS WITH POSITIVE HISTOLOGICAL MARGINS e IS THIS NECESSARY?
Victor Ki-Shing Miu, Dua Saeed, Jasmine Tang, Paolo Matteucci. Castle Hill Hospital, Hull, UK. Most BCCs are treated with excision although depending on the nature of the lesions, other treatment modalities can be used. The British Association of Dermatologists issued a guideline in 2008 for the management of BCCs.
It is suggested that all BCCs with positive margins will needed to be treated by re-excision. Methods: Retrospective case-note analysis of all BCCs excised over a oneyear-period in our unit. Results: 745 procedures were performed. 51 out of 86 incomplete BCC excisions received re-excision. 53% of all re-excision specimens had no residual BCCs. However, with high risk histological subtypes, the negative re-excision rates decrease to 47%. In the low risk histological subgroup, specimens contained no residual BCCs in 80% of the cases of re-excision. 15 high risk BCCs with positive margins were treated conservatively; of which 3 had a recurrence of their BCCs (20%). In low risk subtype all 9 patients receiving conservative treatment, have no evidence of recurrence to date. Conclusion: Large numbers of re-excision specimens for 'positive margin' BCCs, contained no residual BCC. This is especially true in the low risk subtype BCC. However, each patient should be assessed on a case by case basis and offered re-excision or surveillance where appropriate.
1283: TETANUS IMMUNISATION: DOCUMENTATION AND MANAGEMENT
Jurga Pikturnaite, Margarita Moustaki, Jamil Ahmed, Matthew James. Guys and St Thomas NHS Foundation Trust, London, UK.
